BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 14049078)

  • 1. INVESTIGATIONS ON THE IMMUNOLOGICAL REACTIVITY IN HAEMOBLASTOSES. I. PROPERDIN VALUES IN LEUKAEMIAS, MALIGNANT LYMPHOMAS AND MYELOMAS.
    LIBANSKY J; RYBAK M
    Neoplasma; 1963; 10():261-82. PubMed ID: 14049078
    [No Abstract]   [Full Text] [Related]  

  • 2. INVESTIGATIONS OF THE IMMUNOLOGICAL REACTIVITY IN HAEMOBLASTOSES. III. CIRCULATING ANTIBODY FORMATION AS A RESPONSE TO ANTIGENIC STIMULUS IN LEUKAEMIA, MALIGNANT LYMPHOMA, MYELOMA AND MYELOFIBROSIS.
    LIBANSKY J
    Neoplasma; 1963; 10():621-39. PubMed ID: 14103649
    [No Abstract]   [Full Text] [Related]  

  • 3. INVESTIGATIONS OF THE IMMUNOLOGICAL REACTIVITY IN HAEMOBLASTOSES. II. BLOOD COMPLEMENT VALUES IN LEUKAEMIA, MALIGNANT LYMPHOMA, AND MYELOMA.
    LIBANSKY J; JEZKOVA Z
    Neoplasma; 1963; 10():605-19. PubMed ID: 14103648
    [No Abstract]   [Full Text] [Related]  

  • 4. INVESTIGATIONS OF THE IMMUNOLOGICAL REACTIVITY IN HAEMOBLASTOSES. IV. THE BACTERICIDAL PROPERTIES OF THE SERUM AGAINST GRAM-POSITIVE MICROBES IN PATIENTS SUFFERING FROM LEUKAEMIA, MALIGNANT LYMPHOMA, MYELOMA, AND MYELOFIBROSIS.
    LIBANSKY J; JEZKOVA Z
    Neoplasma; 1964; 11():71-87. PubMed ID: 14116776
    [No Abstract]   [Full Text] [Related]  

  • 5. STUDY OF IMMUNOLOGIC REACTIVITY IN HEMOBLASTOSIS. CIRCULATING ANTIBODY FORMATION AS A RESPONSE TO ANTIGENIC STIMULUS IN LEUKEMIA, MALIGNANT LYMPHOMA, MYELOMA AND MYELOFIBROSIS.
    LIBANSKY J
    Blood; 1965 Feb; 25():169-78. PubMed ID: 14267693
    [No Abstract]   [Full Text] [Related]  

  • 6. [STUDIES ON THE IMMUNOLOGICAL REACTIVITY IN HEMOBLASTOSES. V. ISOHEMAGGLUTININ VALUES IN LEUKEMIAS, MALIGNANT LYMPHOMAS, MYELOMAS AND MYELOFIBROSES].
    LIBANSKY J; KOUT M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1964; 82():238-55. PubMed ID: 14345897
    [No Abstract]   [Full Text] [Related]  

  • 7. INFECTIONS, FEVER AND HOST RESISTANCE IN NEOPLASTIC DISEASES.
    SILVER RT
    J Chronic Dis; 1963 Jul; 16():677-701. PubMed ID: 14047258
    [No Abstract]   [Full Text] [Related]  

  • 8. The investigation of the immunological reactivity of patients with haemoblastosis.
    Libánský J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1965; 84(2):172-89. PubMed ID: 4161254
    [No Abstract]   [Full Text] [Related]  

  • 9. HEMORRHAGE IN SURGERY IN MYELOFIBROSIS, MULTIPLE MYELOMA, LEUKEMIA, AND LYMPHOMAS.
    GILBERT HS; WASSERMAN LR
    Ann N Y Acad Sci; 1964 Jul; 115():169-78. PubMed ID: 14192822
    [No Abstract]   [Full Text] [Related]  

  • 10. [ATTEMPT AT TREATMENT OF HODGKIN'S DISEASE AND VARIOUS HEMATOSARCOMAS WITH 1-METHYL-2-P-ALLOPHANOYL-BENZYLHYDRAZINE HYDROBROMIDE].
    MATHE G; SCHNEIDER M; CATTAN A; AMIEL JL; SCHWARZENBERG L; SCHLUMBERGER JR
    Rev Fr Etud Clin Biol; 1964 Nov; 9():990-2. PubMed ID: 14232681
    [No Abstract]   [Full Text] [Related]  

  • 11. [EARLY DIAGNOSIS OF MALIGNANT BLOOD DISEASES].
    AUDO-GIANOTTI GB
    Cancro; 1963; 16():64-83. PubMed ID: 14116527
    [No Abstract]   [Full Text] [Related]  

  • 12. [TRIAL TREATMENT BY A METHYLHYDRAZINE OF HODGKIN'S DISEASE AND VARIOUS HEMATOSARCOMAS AND LEUKEMIAS].
    MATHE G; BERUMEN L; SCHWEISGUTH O; BRULE G; SCHNEIDER M; AMIEL JL; SCHWARZENBERG L
    Nouv Rev Fr Hematol; 1964; 4():327-9. PubMed ID: 14148296
    [No Abstract]   [Full Text] [Related]  

  • 13. Complement in hematological neoplasias.
    Batlle Fonrodona FJ; López Fernández MF; Vicente García V; Corral Alonso M; López Borrasca A
    Allergol Immunopathol (Madr); 1979; 7(1):39-46. PubMed ID: 474324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [THE CLINICAL USE OF CYCLOPHOSPHAMIDE IN MALIGNANT HEMOPATHIES. EVALUATION OF THE RESULTS].
    JAMRA M; MILDER RV; VENTURELLI E
    Rev Assoc Med Bras; 1963 Jun; 9():191-202. PubMed ID: 14096204
    [No Abstract]   [Full Text] [Related]  

  • 15. [Behavior of some manifestations of native immunity in hemoblastoses].
    MILAZZO F; ORTOLANI C
    Boll Ist Sieroter Milan; 1961; 40():141-55. PubMed ID: 13770592
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of haematological malignancies and their treatment on host defence factors.
    Hersh EV; Gutterman JU; Mavligit GM
    Clin Haematol; 1976 Jun; 5(2):425-48. PubMed ID: 780032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [TUBERCULIN ANERGY AS A CRITERION OF BIOLOGICAL DELIMITATION OF MALIGNANT RETICULOPATHIES].
    POPA M; POPA G; VEIZA L
    Med Interna (Bucur); 1964 Jul; 16():811-8. PubMed ID: 14182762
    [No Abstract]   [Full Text] [Related]  

  • 18. [Studies on the properdin system in hemoblastosis].
    Reissmann G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1965; 83(1):1-9. PubMed ID: 4157878
    [No Abstract]   [Full Text] [Related]  

  • 19. Incidence rates of leukemias, lymphomas and myelomas in Italy: geographic distribution and NHL histotypes.
    Masala G; Di Lollo S; Picoco C; Crosignani P; Demicheli V; Fontana A; Funtó I; Miligi L; Nanni O; Papucci A; Ramazzotti V; Rodella S; Stagnaro E; Tumino R; Viganó C; Vindigni C; Seniori Costantini A; Vineis P
    Int J Cancer; 1996 Oct; 68(2):156-9. PubMed ID: 8900420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [CHEMOTHERAPY AND HORMONE THERAPY OF MALIGNANT HEMOPATHIES AND CANCERS. PRACTICAL TREATMENT PROCEDURE].
    JACQUILLAT C; WEIL M
    Fr Med; 1963 Dec; 26():583-91. PubMed ID: 14113068
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.